All Articles Tagged ‘celebrity speaker’
Tuesday, June 15th, 2010

ROCKVILLE, MD: Dr. Mehmet Oz is driving the PR element of a PSA campaign from the Agency for Healthcare Research and Quality (AHRQ), in partnership with the Ad Council, that aims to get more men to take preventative medical tests.
“We used the idea of men not being there for their family—we wanted to tug on > Read More
Tags: Ad Council, celebrity doctors, celebrity speaker, disease awarness campaign, Dr. Mehmet Oz, Dr. Oz, men's health, speaker, website campaign
Talk Back |
No Comments
Wednesday, June 9th, 2010

Washington, D.C. (June 9, 2010) – Legendary pitcher Don Sutton will appear on June’s episode of Sharing Miracles – a 30-minute public affairs television program that tells the compelling and inspirational stories of real patients. Sharing Miracles airs on more than 300 television stations nationwide.
Sutton retired from the majors in 1988 after a remarkable 22-year > Read More
Tags: athletes with cancer, athletes with kidney cancer, cancer survivor, celebrity campaign, celebrity speaker, Darryl Strawberry, deep vein thrombosis, disease awareness PSA, Don Sutton, Jerome Bettis, Jerry Mathers, Jim Sundberg, Joe Torre, John Kruk, kidney cancer, major league baseball, Marcia Gay Harden, Mike Ditka, Naomi Judd, non-hodgkins lymphoma, pharmaceutical manufacturer's association, PhRma, Sharing Miracles, Tedy Bruschi
Talk Back |
No Comments
Friday, May 14th, 2010

GlaxoSmithKline is launching a Nicorette lozenge with a snarky new iteration of the “Quitting Sucks” ad campaign and a Facebook contest starring TV shrink Dr. Drew Pinsky.
The Nicorette Mini Lozenge features a “discreet pocket-size vial,” not dissimilar to the packaging for Mentos. GSK boasts that the lozenge, GSK’s first, “dissolves up to three times faster > Read More
Tags: addiction, awareness campaign, celebrity doctor, Celebrity Rehab, celebrity speaker, Dr. Drew Pinsky, GlaxoSmithKline, GSK, Loveline, Nicorette, Nicorette Mini Lozenge, pharmaceutical ad campaign, smoking cessation, VH1
Talk Back |
No Comments